# GEOC

> GEOC is a VC fund in Shanghai backing Health Care and Medical Device. See 9 investments, check sizes, portfolio and contact details. Updated Aug 2026.

- Type: VC Fund
- Location: Shanghai, China
- Total investments: 9
- Last investment: May 2018
- Lead investor: 22%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/company/7937569?trk=vsrp_companies_cluster_name&trkInfo=VSRPsearchId%3A3817070931470654931416%2CVSRPtargetId%3A7937569%2CVSRPcmpt%3Acompanies_cluster
- Website: http://www.gocapitalgp.com

GEOC is a VC fund in Shanghai focused on Health Care and Medical Device. Go Capital & EOC (GEOC) is an investment firm that invests in Israeli high-tech companies in areas of life Sciences, 3D printing, AI, IOT, and etc.GEOC has experienced Chinese and Israeli teams with business and international expertise which is complementary in territory, domain and resources. In the past 20 years, the core teams of bothChina and Israel have been focusing on advancing those areas of interest.The Fund identified the growing potential in China – Israel relations in the political and economic arenas with complementary objectives and growing business opportunities.GEOC's vision is to be the innovation platform and growth engine for deep integration of advanced Israeli technology and Chinese manufacturing industry and huge market.

## Contacts

5 contacts available for GEOC. Shizune tracks 4 team members at GEOC. Sign up free to unlock them: https://app.shizune.co/sign-up/investor-profiles/find-team-emails/geoc-hengtong-investment-limited-partnership?utm_source=investor_profile

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Health Care | 4 | 44% |
| Medical Device | 4 | 44% |
| Manufacturing | 3 | 33% |
| Medical | 2 | 22% |
| Biotechnology | 2 | 22% |

25 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Series B | 2 | 22% |
| Series E | 2 | 22% |
| Funding Round | 2 | 22% |
| Angel | 1 | 11% |
| Series A | 1 | 11% |

6 stages tracked in total.

### Country

| Country | Investments | Share |
| --- | --- | --- |
| Israel | 6 | 67% |
| China | 2 | 22% |

## Team

| Name | Title | Investments | Profile |
| --- | --- | --- | --- |
| Qiang Ma | Founder, Partner | 0 | https://shizune.co/investors/profile/qiang-ma |
| Shalom Tourgeman | Managing Director | 0 | https://shizune.co/investors/profile/shalom-tourgeman |
| Hanjiang Xu | Founder and Managing Partner | 0 | https://shizune.co/investors/profile/hanjiang-xu |
| Weiping Gu | Founder, Partner | 0 | https://shizune.co/investors/profile/weiping-gu |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Vectorious Medical Technologies | Vectorious Medical Technologies developed the V-LAP, the worlds first in-heart microcomputer which enables optimal treatment for heart failure patients, increasing their quality of life and life expectancy. The V-LAP sensory implant is the first digital, wireless, battery-less device that is able to communicate from deep within the body. Itmonitors the heart’s left atrium pressure (LAP) which has been proven to be the earliest, most accurate and effective predictor for heart failure deterioration. Vectorious is actively conducting clinical studies in Europe (Italy, Germany, UK and Israel) for the purpose of obtaining a CE mark. It is expected to launch a clinical study in the US in 2020. | $9M | Series B | May 09, 2018 |  |
| InSightec | InSightec is the pioneer and global leader in MR guided focused ultrasound technology for image guided acoustic surgery.ExAblate® 2000 system was the first system to use the MR guided focused ultrasound technology. The ExAblate system received CE mark in 2002 and the Food and Drug Administration (FDA) approval in 2004 for the treatment ofsymptomatic uterine fibroids. ExAblate received the European CE Mark for pain palliation of bone metastases in June 2007 and for adenomyosis in June 2010. This device has won numerous innovation awards and has been used to treat thousands of patients around the world. | $150M | Series E | Dec 14, 2017 |  |
| Sight Diagnostics | Sight Diagnostics is a blood diagnostic company that combines machine vision and AI to improve health through fast, convenient and accurate diagnostics. Developed over almost a decade of research, Sight’s technology combines the latest innovations in blood sample preparation, optics, chemistry, biology, physics and computer science.Sight’s firstproduct, Parasight*, has diagnosed malaria in close to 1 million tests across 24 countries. Sight OLO, Sight’s latest FDA 510(k) cleared blood analyzer, digitizes blood with only 2 drops of a finger prick or venous sample and provides lab-grade Complete Blood Count results in minutes. Sight has growing offices in the UK, the US and Israel, and commercial footprint on 5 continents.*Note: Parasight is not available for sale in the US and did not receive FDA clearance for use in the US. | $16M | Series B | Sep 01, 2016 |  |
| Highcon | Highcon delivers innovation and differentiation that converters, printers, and brand owners all need, transforming “finishing” into a value adding process to positively impact users’ profitability by increasing speed to market, eliminating costly production steps and reducing carbon footprint. The Highcon Euclid is the first fully digital cuttingand creasing machine for converting paper, labels, folding carton and microflute. The Euclid incorporates Highcon’s patented ‘DART’ (Digital Adhesive Rule Technology) to produce creases, and high-speed laser optics to for cutting and etching. Contact info +972-8-9101705 web site: www.highcon.net | $20M | Series E | Feb 09, 2015 |  |
| Kaymera | Kaymera was founded by veterans in the cyber industry with in depth knowledge and expertise in mobile security and cyber attack methods to assess and breach stringent security measures. Kaymera delivers the most sophisticated defense system to protect organizations, governments and individuals from all mobile security threats, while supportingfreedom of use on popular smartphone models.Kaymera ensures anr an organization is protected, yet employees have a seamless experience. Offering personalized security: matching the risk level, employee context, and organization policy to the level of security applied. From a secured device to BYOD/CYOD, managing stringent policies all the way to un-managed policies. | $13M | Series A | Jan 01, 2015 |  |
| InSightec | InSightec is the pioneer and global leader in MR guided focused ultrasound technology for image guided acoustic surgery.ExAblate® 2000 system was the first system to use the MR guided focused ultrasound technology. The ExAblate system received CE mark in 2002 and the Food and Drug Administration (FDA) approval in 2004 for the treatment ofsymptomatic uterine fibroids. ExAblate received the European CE Mark for pain palliation of bone metastases in June 2007 and for adenomyosis in June 2010. This device has won numerous innovation awards and has been used to treat thousands of patients around the world. | $59M | Series D | Dec 15, 2014 |  |
| Cnoga Medical | Cnoga Medical is an innovative developer of easy-to-use, non-invasive medical devices for personal use. With a vision of empowering people, Cnoga Medical is helping to realize a future where people conduct simple, needle-free blood tests in the comfort of their own homes. Seeing a growing need for painless, non-invasive / touch free medicaltechnology, former CEO and founder of OPlus Technology Dr. Yosef Segman established Cnoga Medical in the technology hub of Israel in 2004. Cnoga Medical works with international prominent technology companies such as Texas Instruments and PNY Inc., which dominates the US flash memory market. At the same time, Cnoga Medical remains focused on research and development into enhancing and developing its range of non-invasive technologies. The Cnoga Medical team’s combined decades of extensive international experience have earned it the ability to distribute to countries in Europe, East and Southeast Asia, South America and the Middle-East. | $12.5M |  | Oct 27, 2014 |  |
| Zilin | Zilin Vinegar Industry is a brewing industry with microbial fermentation as its core technology, and an enterprise in agricultural industrialization vinegar brewing industry. Their product includes vinegar, fruit vinegar, vinegar drink, cooking wine, soy sauce, soybean paste, sesame oil, tahini, health vinegar, and gift vinegar. | $425K | Angel | May 31, 2012 |  |
| JXJ | Jiaxinjie manufactures video products. They provide integrated social video smart campus, urban management community, and secret security system solutions for the government, public security, transportation, energy, education, and construction sectors. | $10.8M |  | May 03, 2012 |  |

9 of 9 investments shown.

## Co-investors
- [Elbit Imaging Ltd.](https://shizune.co/investors/profile/elbit-imaginh-ltd) — VC Fund, 2 deals together
- [GE Healthcare](https://shizune.co/investors/profile/ge-healthcare) — VC Fund, 2 deals together
- [York Capital Management](https://shizune.co/investors/profile/york-capital-management) — VC Fund, 2 deals together
- [Broadview Ventures](https://shizune.co/investors/profile/broadview-ventures) — VC Fund, 1 deal together
- [Eagle Investment Holdings](https://shizune.co/investors/profile/eagle-investment-holdings) — VC Fund, 1 deal together
- [Focus Holdings](https://shizune.co/investors/profile/focus-holdings) — VC Fund, 1 deal together

## Similar investors

### Similar industry
- [Innova Memphis](https://shizune.co/investors/profile/innova-memphis) — VC Fund
- [SOSV](https://shizune.co/investors/profile/sosv) — VC Fund
- [Enterprise Ireland](https://shizune.co/investors/profile/enterprise-ireland) — VC Fund

### Similar stage
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund
- [FJ Labs](https://shizune.co/investors/profile/fj-labs) — VC Fund

### Similar country
- [F6 Ventures](https://shizune.co/investors/profile/flat6labs) — VC Fund
- [Oqal](https://shizune.co/investors/profile/oqal) — VC Fund
- [Alesta Yatırım](https://shizune.co/investors/profile/alesta-girisim) — VC Fund

## Featured in investor lists
- [Medical Device VC Funds in Middle East](https://shizune.co/investors/medical-device-vc-funds-middle-east)

## FAQ

### What does GEOC invest in?

GEOC invests primarily in Health Care, Medical Device and Manufacturing startups, most often at Series B and Series E stage. Most of the 9 investments tracked by Shizune back companies in Israel. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### How do I contact GEOC?

Public channels for GEOC include LinkedIn and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

### Who are the partners at GEOC?

The team at GEOC includes Qiang Ma (Founder, Partner), Shalom Tourgeman (Managing Director) and Hanjiang Xu (Founder and Managing Partner). The Team section lists each member with their title, investment count and links.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co